Q3 2018 Otonomy Inc Earnings Call
Conference Call Otonomy Inc
Otonomy Inc Conference call will be held on Nov 5, 2018. During the earnings conference call's session Otonomy Inc will provide updated information and financial status.
Conference call service enable to conduct an online meeting with several participates at the same time without leaving the room. Earnings call use teleconference platform to conduct an online meeting between the management of a public company, analysts, investors and the media to discuss the financial results during a given reporting period
In order to join the earnings online meeting, contact Otonomy Inc for the information on connecting using web conferencing or bridge number and PIN code
Schedule an online meeting with QCONF conference service and get free conference bridge.
Otonomy is a biopharmaceutical company focused on the development and commercialization of innovative therapeutics for diseases and disorders of the ear. OTIPRIO(TM) (ciprofloxacin otic suspension) is the first drug approved in the United States for use during tympanostomy tube placement (TTP) surgery and is available for commercial purchase as of March 1, 2016. OTIPRIO is also being evaluated for potential label expansion in acute otitis externa (also known as "swimmer's ear") and acute otitis media with tympanostomy tube (AOMT). OTO-104 is a steroid in development for the treatment of Ménière's disease and other balance and hearing disorders. A Phase 3 trial in Ménière's disease patients has been initiated in the United States with a second trial expected to be initiated in the European Union (EU) during the first quarter of 2016.Read more Conference Call